Skip to main content
$0.015 (0%)

High

$0.02

Low

$0.02

Trades

21

Turnover

$27,023

Volume

1,798,203
30 June 2023 at 2:47pm
If you were already registered, log in here.

Short Interest

ASIC data, 17 Dec 2020

% Shorted

0.01%
vs 0.01% prior report

Most Shorted Rank

538th
of 711 shorted ASX stocks

Peak Short

0.16%
Nov 2017

Days to Cover

0.1
at 50d avg vol
Subject
LCT Ann: Cleansing Notice

LCT Ann: Proposed issue of securities - LCT

LCT Ann: LCT to Issue Compensation Options

LCT Ann: Update - Proposed issue of securities - LCT

LCT Ann: Extension of Rights Issue

LCT Ann: Appendix 2A- Issue of shares and Options

LCT Ann: Proposed issue of securities - LCT

LCT Ann: Cleansing Notice

LCT Ann: Results of General Meeting

LCT Ann: Chairman Presentation

LCT Ann: Chairman's Address to the General Meeting

LCT Ann: Non-Renounceable Rights Issue Opens

LCT Ann: Update - Proposed issue of securities - LCT

LCT Ann: Proposed issue of securities - LCT

LCT Ann: Prospectus- Rights Issue

LCT Ann: LCT- Rights Issue

LCT Ann: Results of Annual General Meeting

LCT Ann: CEO's presentation to AGM

LCT Ann: Chairman's Address to the 2021 Annual General Meeting

LCT Ann: LCT Receives New Zealand R&D Tax Credit

LCT Ann: LCT Advises Price Change for Rights Issue

LCT Ann: Quarterly Activity Report and Appendix 4C

LCT Ann: Notice of General Meeting/ Proxy Form

LCT Ann: LCT Signs MOU with NZeno, Secures Pig Cells for NTCELL Trial

LCT Ann: Application for quotation of securities - LCT

LCT Ann: Cleansing Notice

LCT Ann: Proposed issue of securities - LCT

LCT Ann: Secures Funds for 3rd Trial of NTCELL in Parkinson Disease

LCT Ann: Trading Halt

LCT Ann: Pause in Trading

LCT Ann: Appendix 4G and Corporate Governance Statement

LCT Ann: Annual Report to shareholders

LCT Ann: 2021 Annual General Meeting

LCT Ann: Notification of cessation of securities - LCT

LCT Ann: Preliminary Final Report and 2021 Financial Statements

LCT Ann: Business Update

LCT Ann: Quarterly Activity Report and Appendix 4C

LCT Ann: Appendix 3Z - K Taylor

LCT Ann: LCT Interim CEO Appointed

LCT Ann: Response to ASX Price Query

LCT Ann: Change of Director's Interest Notice - K Taylor

LCT Ann: Notification of cessation of securities - LCT

LCT Ann: Business Update

LCT Ann: Quarterly Activity Report and Appendix 4C

LCT Ann: LCT exits peptide projects

LCT Ann: Half Yearly Report and Accounts

LCT Ann: Change in substantial holding

LCT Ann: Change in substantial holding

LCT Ann: Response to ASX Price Query

LCT Ann: Quarterly Activity Report and Appendix 4C

If you were already registered, log in here.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX
S88
MAV
ATW $7.5m raise
RDO $30m raise
ABC $5m raise
RGS
MBM